Previous 10 | Next 10 |
According to presentation slides , CURO Group Holdings (NYSE: CURO ) expects Q2 revenue of $180M to $190M vs. $207.25M consensus and EPS of $0.40 to $0.55 vs. $0.36 consensus. More news on: CURO Group Holdings Corp., Financial stocks news, , Stocks on the move, Read more ...
Thesis Subprime consumer lenders are classic Peter Lynch stocks because they are considered distasteful, they are small-caps, and they are usually very profitable. The end result are stocks that are often undervalued in the best of times and dirt-cheap in the worst of times like now. Man...
CURO Group Holdings Corp. (NYSE: CURO) (“CURO” or the “Company”), a market leader in providing short-term credit to underbanked consumers, today announced that members of its executive team will participate in the following conferences: William Blair 40 th An...
NEW ORLEANS , May 8, 2020 /PRNewswire/ -- Former Attorney General of Louisiana , Charles C. Foti, Jr., Esq. , a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into CURO Group Holdings Corp. (NYSE: CURO). ...
Image source: The Motley Fool. CURO Group Holdings Corp. (NYSE: CURO) Q1 2020 Earnings Call May 1, 2020 , 8:15 a.m. ET Operator Continue reading
CURO Group Holdings Corp. (CURO) Q1 2020 Results Earnings Conference Call May 1, 2020, 08:15 AM ET Company Participants Gar Jackson - Investor Relations, Global IR Group Don Gayhardt - President and Chief Executive Officer Roger Dean - Executive Vice President and Chief Financial...
Curo Group (NYSE: CURO ): Q1 Non-GAAP EPS of $0.77 misses by $0.12 ; GAAP EPS of $0.86 beats by $0.04 . More news on: CURO Group Holdings Corp., Earnings news and commentary, Financial stocks news, Read more ...
CURO Group Holdings Corp. (NYSE: CURO) (“CURO” or the “Company”), a market leader in providing short-term credit to underbanked consumers, today announced financial results for its first quarter ended March 31, 2020. “After a very promising start to the ...
Gainers: Yield10 Bioscience (NASDAQ: YTEN ) +68% . More news on: Yield10 Bioscience, Inc., Aytu BioScience, Inc., Avadel Pharmaceuticals plc, Stocks on the move, , Read more ...
Axsome Therapeutics (NASDAQ: AXSM ) +44% as Avadel Pharmaceuticals gains 34% on positive data on lead drug. More news on: Axsome Therapeutics, Inc., Avadel Pharmaceuticals plc, Yield10 Bioscience, Inc., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
CURO Group Holdings Corp. Company Name:
CURO Stock Symbol:
NYSE Market:
RSA Supported by More Than 74% of each of 1L Lenders, 1.5L Noteholders and 2L Noteholders Filed Voluntary Chapter 11 Petitions to Implement Financial Restructuring Plan Restructuring Plan Expected to Reduce Debt by ~$1 billion, Saving ~$75 million in Cash Interest Annually and Ena...
CURO Group Holdings Corp. (OTC: CURO) (“CURO” or the “Company”), an omni-channel consumer finance company serving consumers in the United States and Canada, today announced that it has received notice on behalf of certain holders of the Company’s 7.500% Senior 1...
CURO Group Holdings Corp. (NYSE: CURO) (“CURO” or the “Company”), an omni-channel consumer finance company serving consumers in the United States and Canada, today announced that it entered into forbearance agreements (the “Forbearance Agreements”) with t...